Oriola (ORIOLA.HE) stock: key figures, P/E, revenue and dividend

Health Care · Finland · ISIN FI0009014351

Price

0.78 EUR

Market cap

143.14 m EUR

P/E (2025)

–

P/S (2025)

0.08

Dividend yield

3.86 %

Net margin

-1.43 %

Return on equity (ROE)

-26.98 %

Return on assets (ROA)

-2.87 %

Oriola financials

Fiscal year	2024	2025
Revenue	1.68 bn EUR	1.91 bn EUR
Gross profit	160.50 m EUR	67.90 m EUR
Operating income	13.50 m EUR	7.30 m EUR
EBIT	-14.30 m EUR	7.30 m EUR
Net income	-20.10 m EUR	-27.20 m EUR
Diluted EPS – continuing operations	-0.11 EUR	-0.15 EUR

Full history since 2004, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Oriola

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tenders, real world evidence, sales support, medical translation, pharmacovigilance and medical information, and patient support services. Further, the company provides advisory services. It serves pharmaceutical companies, pharmacies, veterinarians, hospitals, healthcare providers, special stores, retailers, and e-commerce companies. The company was founded in 1907 and is headquartered in Espoo, Finland.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.